Weakness of sympathetic neural control of human pial compared with superficial temporal arteries reflects low innervation density and poor sympathetic responsiveness

Stroke

Volumn 29, Issue 1, 1998, Pages 212-221

  Bevan, Rosemary D ^a   Dodge, John ^a   Nichols, Patricia ^a   Penar, Paul L ^b   Walters, Carrie L ^c   Wellman, Terry ^a   Bevan, John A ^a  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c Neurological Surgeons   (United States)

Author keywords

Adrenergic responses; Pial artery; Sympathetic innervation; Temporal arteries

Indexed keywords

ACETYLCHOLINE; ALPHA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; INDOMETACIN; ISOPRENALINE; NITRIC OXIDE; NORADRENALIN; PROPRANOLOL;

ADOLESCENT; ADRENERGIC SYSTEM; ADULT; AGED; ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL TONE; DOSE RESPONSE; ELECTRON MICROSCOPY; ELECTROSTIMULATION; FLUORESCENCE HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENINGEAL ARTERY; MYOGRAPHY; NERVE STIMULATION; PIA ARTERY; PRIORITY JOURNAL; SUPERFICIAL TEMPORAL ARTERY; SYMPATHETIC INNERVATION;

EID: 0031974356     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.1.212     Document Type: Article

References (53)

1. Bevan JA, Bevan RD, Duckles SP. Adrenergic regulation of vascular smooth muscle. In: Bohr DF, Somlyo AP, Sparks HV, eds. Handbook of Physiology, Sec. 2: The Cardiovascular System, Vol. 2: Vascular Smooth Muscle. Baltimore, Md: American Physiology Society; 1980:515-566.
2. Edvinsson L, MacKenzie E, McCulloch J. Cerebral Blood Flow and Metabolism. New York, NY: Raven Press; 1993.
3. Traystman RJ, Rapela CE. Effect of sympathetic nerve stimulation on cerebral and cephalic blood flow in dogs. Circ Res. 1975;36:620-630.
4. D'Alecy LG, Feigl EO. Sympathetic control of cerebral blood flow in dogs. Circ Res. 1972;31:267-283.
5. Purves MJ. Do vasomotor nerves significantly regulate cerebral blood flow? Circ Res. 1978;43:485-493.
6. Heistad DD, Marcus ML. Neural control of cerebral blood flow. Circ Res. 1978;42:295-302.
7. Bevan JA. Autonomic pharmacologist's guide to the cerebral circulation. Trends Pharmacol Sci. 1984;5:234-236.
8. Shibata S, Cheng JB, Murakami W. Reactivity of isolated human cerebral arteries to biogenic amines. Blood Vessels. 1975;14:356-365.
9. Edvinsson L, Owman C, Sjöberg NO. Autonomic nerves, mast cells, and amine receptors in human brain vessels: a histochemical and pharmacological study. Brain Res. 1976;115:377-393.
10. Duckworth JW, Wellman GC, Walters CL, Bevan JA. Aminergic histofluorescence and contractile responses to transmural electrical field stimulation and norepinephrine of human middle cerebral arteries obtained promptly after death. Circ Res. 1989;65:316-324.
11. Toda N, Fujita Y. Responsiveness of isolated cerebral and peripheral arteries to serotonin, norepinephrine, and transmural electrical stimulation. Circ Res. 1973;33:98-104.
12. Hardebo JE, Hanko J, Kåhrström J, Owman C. Electrical field stimulation in cerebral and peripheral arteries: a critical evaluation of the contractile response. J Auton Phartnacol. 1986;6:85-96.
13. VanRiper DA, Bevan JA. Selective variation of agonist and neurally mediated vasoconstriction with rabbit middle cerebral artery branch order. J Pharmacol Exp Ther. 1991;257:879-886.
14. Elliott SR, Pearce WJ. Effects of maturation on α-adrenergic receptor affinity and occupancy in small cerebral arteries. Am J Physiol. 1994;267: H757-H763.
15. Robertson WM, Welch KM, Levine SR, Schultz LR. The effects of aging on cerebral blood flow in migraine. Neurology. 1989;39:947-951.
16. Docherty JR. Functional changes in the aging cerebrovasculature. In: Bevan RD, Bevan JA, eds. Human Brain Circulation. Totowa, NJ: Humana Press; 1994:271-280.
17. Wellman GC, Wellman TD, Dunn WR, Bevan RD, Bevan JA. Preservation of function of isolated blood vessels after storage. J Vasc Med Biol. 1993;4;47-53.
18. Bevan JA, Osher JV. A direct method for recording tension changes in the wall of small blood vessels in vitro. Agents Actions. 1972;2:257-260.
19. Mulvany MJ, Halpern W. Mechanical properties of vascular smooth muscle cells in situ. Nature (Lond). 1976;260:617-619.
20. Lindvall O, Björklund A. The glyoxylic acid fluorescence histochemical method: a detailed account of the methodology for the visualization of central catecholamine neurons. Histochemistry. 1974;39:97-127.
21. Cowen T, Haven AJ, Burnstock G. Pontamine sky blue: a counterstain for background autofluorescence in fluorescence and immunofluorescence histochemistry. Histochemistry. 1985;82:205-208.
22. Lombard JH, Eskinder H, Kauser K, Osborn JL, Harder DR. Enhanced norepinephrine sensitivity in renal arteries at elevated transmural pressure. AmJ Physiol 1990;259:H29-H33.
23. Dunn WR, Wellman GC, Bevan JA. Enhanced resistance artery sensitivity to agonists under isobaric compared with isometric conditions. Am J Physiol. 1994;266:H147-H155.
24. Bauknight GC Jr, Faraci FM, Heistad DD. Endothelium-derived relaxing factor modulates noradrenergic constriction of cerebral arterioles in rabbits. Stroke. 1992;23:1522-1526.
25. Shibata S. The effect of drugs on the autonomic neuroeffector system of cerebral arteries. In: Carrier O Jr, Shibata S, eds. Factors Influencing Vascular Reactivity. Tokyo, Japan: Igaku-Shoin Ltd; 1977:132-155.
26. Jansen I, Uddman R, Ekman R, Olesen J, Ottosson A, Edvinsson L. Distribution and effects of neuropeptide Y, vasoactive intestinal peptide, substance P, and calcitonin gene-related peptide in human middle meningeal arteries: comparison with cerebral and temporal arteries. Peptides. 1992;13:527-536.
27. Hardebo JE, Hanko J, Owman C. Differences between human intra- and extracranial arteries in their reactivity to vasoactive agents. Gen Pharmacol. 1983;14:133-134.
28. Müller-Schweinitzer E, Weidmann H. Regional differences in the responsiveness of isolated arteries from cattle, dog and man. Agents Actions. 1977;7:383-389.
29. Jauernig RA, Moulds RFW. A human arterial preparation for studying the effects of vasoactive agents. Circ Res. 1978;42:363-368.
30. Bevan JA, Oriowo MA, Bevan RD. Physiological variation in a-adrenoceptor-mediated arterial sensitivity: relation to agonist affinity. Science. 1986;234:196-197.
31. Bevan JA, Van Riper D. Sympathetic influences on cerebrovascular tone. In: Neurotransmission and Cerebrovascular Function II. New York, NY: Elsevier Science Publishers BV; 1989.
32. Laher I, Bevan JA. Alpha adrenoceptor number limits response of some rabbit arteries to norepinephrine. J Pharmacol Exp Ther. 1985;233:290-297.
33. Jonsson G. Quantitation of fluorescence of biogenic amines. Prog Htistochem Cytochem. 1971;2:299-334.
34. Nielsen KC, Owman C. Adrenergic innervation of pial arteries related to the circle of Willis in the cat. Brain Res. 1967;6:773-776.
35. Bevan JA, Bevan RD, Frazee JG. Functional arterial changes in chronic cerebrovasospasm in monkeys: an in vitro assessment of the contribution to arterial narrowing. Stroke. 1987;18:472-481.
36. Akiguchi I, Fukuyama H, Kameyama M, Koyama T, Kimura H, Maeda T. Sympathetic nerve terminals in tunica media of human superficial temporal and middle cerebral arteries: wet histofluorescence. Stroke. 1983;14:62-66.
37. Lee TJ-F, Su C, Bevan JA. Neurogenic sympathetic vasoconstriction of the rabbit basilar artery. Circ Res. 1976;39:120-126.
38. Duckles SP. Neurogenic dilator and constrictor responses of pial arteries in vitro. Circ Res. 1979;44:482-490.
39. Lee TJ-F, Hume WR, Su C, Bevan JA. Neurogenic vasodilation of cat cerebral arteries. Circ Res. 1978;42:535-542.
40. Owen MP, Walmsley JG, Mason MF, Bevan RD, Bevan JA. Adrenergic control in three artery segments of diminishing diameter in the rabbit ear. Am J Physiol. 1983;245:H320-H326.
41. Winquist RJ, Webb RC, Bohr DF. Relaxation to transmural nerve stimulation and exogenously added norepinephrine in porcine cerebral vessels: a study utilizing cerebrovascular intrinsic tone. Circ Res. 1982;51:769-776.
42. Edvinsson L, Owman C, Sjöberg NO. Autonomic nerves, mast cells, and amine receptors in human brain vessels: a histochemical and pharmacological study. Brain Res. 1976;115:377-393.
43. Miao FJ-P, Lee TJ-F. Cholinergic and vip-ergic innervations in cerebral arteries of the cat. In: Seylaz JS, MacKenzie ET, eds. Neurotransmission and Cerebrovascular Function. Amsterdam: Excerpta Media; 1989:335-338.
44. Jansen I, Uddman R, Ekman R, Olesen J, Ottosson A, Edvinsson L. Distribution and effects of neuropeptide Y, vasoactive intestinal peptide, substance P, and calcitonin gene-related peptide in human middle meningeal arteries: comparison with cerebral and temporal arteries. Peptides. 1992;13:527-536.
45. Jansen I, Uddman R, Hocherman M, Ekman R, Jensen K, Olesen J, Stiernholm P, Edvinsson L. Localization and effects of neuropeptide Y, vasoactive intestinal polypeptide, substance P, and calcitonin gene-related peptide in human temporal arteries. Ann Neurol. 1986;20:496-501.
46. Toda N. Nitric Oxide (NO), and the regulation of cerebral arterial tone. In: Vincent SR, ed. Nitric Oxide in the Nervous System. Academic Press; 1995:207-225.
47. Bevan JA, Brayden JE. Nonadrenergic neural vasodilator mechanisms. Circ Res. 1987;60:309-326.
48. Shibata S. The effect of drugs on the autonomic neuroeffector system of cerebral arteries. In: Carrier O Jr, Shibata S, eds. Factors Influencing Vascular Reactivity. Tokyo, Japan: Igaku-Shoin Ltd; 1977.
49. Nielsen KC, Owman C. Contractile response and amine receptor mechanisms in isolated middle cerebral artery of the cat. Brain Res. 1971;27:33-42.
50. Koller A, Kaley G. Prostaglandins mediate arteriolar dilation to increased blood flow velocity in skeletal muscle microcirculation. Circ Res. 1990;67: 529-534.
51. Sadoshima S, Busija D, Brody M, Heistad D. Sympathetic nerves protect against stroke in stroke-prone hypertensive rats. Hypertension. 1981;3(suppl I):I-24-I-127.
52. Mueller SM, Black WL Jr. Sympathetic nerve activity: a link to stroke? Stroke. 1985;16:73-75.
53. Bevan RD. Effect of sympathetic denervation on smooth muscle cell proliferation in the growing ear artery. Circ. Res. 1975;37:14-19.